Zhengye Biotechnology Holding (ZYBT) Loans and Notes Receivables: 2023-2025
- Zhengye Biotechnology Holding's Loans and Notes Receivables was N/A to $3.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.5 million, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2024, which is 6.73% up from last year.
- According to the latest figures from Q2 2025, Zhengye Biotechnology Holding's Loans and Notes Receivables is $3.5 million, which was down 0.43% from $3.5 million recorded in Q4 2024.
- In the past 5 years, Zhengye Biotechnology Holding's Loans and Notes Receivables ranged from a high of $3.5 million in Q4 2024 and a low of $3.2 million during Q4 2023.
- Over the past 3 years, Zhengye Biotechnology Holding's median Loans and Notes Receivables value was $3.5 million (recorded in 2025), while the average stood at $3.4 million.
- Data for Zhengye Biotechnology Holding's Loans and Notes Receivables shows a peak YoY climbed of 8.74% (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows Zhengye Biotechnology Holding's Loans and Notes Receivables stood at $3.2 million in 2023, then increased by 8.74% to $3.5 million in 2024, then reached $3.5 million in 2025.
- Its last three reported values are $3.5 million in Q2 2025, $3.5 million for Q4 2024, and $3.2 million during Q4 2023.
